Your browser doesn't support javascript.
Targeting type I interferon (IFN) signalling in patients with RA with a high type I IFN gene signature.
Karonitsch, Thomas; Yeghiazaryan, Lusine; Lackner, Angelika; Brezinsek, Hans Peter; Stamm, Tanja A; König, Franz; Aletaha, Daniel; Smolen, Josef S.
  • Karonitsch T; Division of Rheumatology, Medical University of Vienna, Wien, Austria thomas.karonitsch@meduniwien.ac.at.
  • Yeghiazaryan L; Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Wien, Austria.
  • Lackner A; Division of Rheumatology and Immunology, Medical University of Graz, Graz, Austria.
  • Brezinsek HP; Division of Rheumatology and Immunology, Medical University of Graz, Graz, Austria.
  • Stamm TA; Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Wien, Austria.
  • König F; Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Wien, Austria.
  • Aletaha D; Division of Rheumatology, Medical University of Vienna, Wien, Austria.
  • Smolen JS; Division of Rheumatology, Medical University of Vienna, Wien, Austria.
RMD Open ; 8(2)2022 10.
Article in English | MEDLINE | ID: covidwho-2088877
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Arthritis, Rheumatoid / Interferon Type I Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: Rmdopen-2022-002525

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Arthritis, Rheumatoid / Interferon Type I Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: Rmdopen-2022-002525